Penicillamine Capsule
Product Images NDC 68475-201

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Penicillamine (NDC 68475-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Navinta Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Db4fd2c4 9bd1 4515 B3c0 484ea52a186e 01)

FDA Label Image

Fig (Db4fd2c4 9bd1 4515 B3c0 484ea52a186e 02)

Fig (Db4fd2c4 9bd1 4515 B3c0 484ea52a186e 02)
This is a medication called Penicillamine, USP made in India by GUJDRUGS. Each capsule of Penicillamine contains 250mg of the active ingredient. It is a bulk package and not intended for dispensing to patients. This medication's correct dosage and other information can be found in the package insert. While storing, keep the container tightly closed at a temperature between 20°C to 25°C (68°F to 77°F). The manufacturer of this medication is Navinta LLC located in Ewing, NJ. The package is not child resistant. This medication is available only for prescription and should be used as instructed. However, some text is cropped, and some characters are not recognizable.*
FDA Label Image

Image (Db4fd2c4 9bd1 4515 B3c0 484ea52a186e 253 1)

FDA Label Image

Image (Db4fd2c4 9bd1 4515 B3c0 484ea52a186e 253 2)

FDA Label Image

Image (Db4fd2c4 9bd1 4515 B3c0 484ea52a186e 253 3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.